Inflammatory myocardial injury: the role of lymphocytes in atherosclerosis and other heart diseases

References

• Doherty M, Robertson MJ. Some early trends in immunology. Trends Immunol 2004; 25: 623–31
   Google Scholar
• Australian Bureau of Statistics. National Health Survey: summary of results, Australia, 2004–05. Cat. No. 4364.0. Canberra, ACT: ABS; 2006.
   Google Scholar
• Australian Institute of Health and Welfare. Health system expenditure on disease and injury in Australia, 2000–01, 2nd ed. AIHW Cat. No. HWE 26. Canberra, ACT: AIHW; 2005.
   Google Scholar
• Stary HC, Blankenhorn DH, Chandler AB, Glagov ME, Insull W, Jr, Richardson M, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1992; 85: 391–405
   PubMed Web of Science ®Google Scholar
• Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994; 14: 840–56
   PubMed Web of Science ®Google Scholar
• Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92: 1355–74
   PubMed Web of Science ®Google Scholar
• Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986; 6: 131–8
   PubMedGoogle Scholar
• Munro JM, Van der Walt JD, Munro CS, Chalmers JA, Cox EL. An immunohistochemical analysis of human aortic fatty streaks. Hum Pathol 1987; 18: 375–80
   PubMed Web of Science ®Google Scholar
• Ignatowski AI. Influence of animal food on the organism of rabbits. S Peterb Izv Voyenno-Med Akad 1908; 16: 154–76
   Google Scholar
• Zhang SH, Reddick RL, Burkey B, Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994; 94: 937–45
   PubMed Web of Science ®Google Scholar
• Schwartz SM, Zorina SG, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007; 27: 705–13
   PubMed Web of Science ®Google Scholar
• Hansson GK. Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–95
   PubMed Web of Science ®Google Scholar
• Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 310–8
   PubMed Web of Science ®Google Scholar
• Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation 1994; 89: 503–5
   PubMed Web of Science ®Google Scholar
• Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844–50
   PubMed Web of Science ®Google Scholar
• Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–71
   PubMed Web of Science ®Google Scholar
• Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169–75
   PubMed Web of Science ®Google Scholar
• Gallis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493–503
   Google Scholar
• Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 102: 2883–8
   Google Scholar
• Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the T cell repertoire in patients with unstable angina. Circulation 1999; 100: 2135–9
   PubMed Web of Science ®Google Scholar
• Park W, Weyand CM, Schmidt D, Goronzy JJ. Costimulatory pathways controlling activation and peripheral tolerance of human CD4+ CD28- T cells. Eur J Immunol 1997; 27: 1082–90
   PubMed Web of Science ®Google Scholar
• Namekawa T, Wagner UG, Goronzy JJ, Weyand CM. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 1998; 41: 2108–16
   PubMed Web of Science ®Google Scholar
• Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ. T cell mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002; 105: 570–5
   PubMed Web of Science ®Google Scholar
• Schirmer M, Vallejo AN, Wayand CM, Goronzy JJ. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28null T cells from rheumatoid arthritis patients. J Immunol 1998; 161: 1018–25
   Google Scholar
• Libby P, Egan D, Skarlatos S. Role of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4094–103
   Google Scholar
• Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 1997; 350: 430–6
   PubMed Web of Science ®Google Scholar
• Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404–7
   PubMed Web of Science ®Google Scholar
• Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study: ROXIS Study Group. Lancet 1997; 350: 404–7
   PubMed Web of Science ®Google Scholar
• Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK. Evidence for antigen-driven T cell response in unstable angina. Circulation 2000; 102: 1114–9
   PubMed Web of Science ®Google Scholar
• Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognise oxidised low-density lipoprotein. Proc Natl Acad Sci U S A 1995; 92: 3893–7
   PubMed Web of Science ®Google Scholar
• Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 2002; 22: 1547–59
   PubMed Web of Science ®Google Scholar
• Mosorin M, Surcel HM, Laurila A, Lehtinen M, Karttunen R, Juvonen J, et al. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler Thromb Vasc Biol 2000; 20: 1061–7
   PubMed Web of Science ®Google Scholar
• Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterised by autoreactivity. J Clin Invest 1996; 97: 2027–37
   PubMed Web of Science ®Google Scholar
• Zal B, Kaski JC, Arno G, Akiyu JP, Xu Q, Cole D, et al. Heat shock protein 60-reactive CD4+ CD28null T cells in patients with acute coronary syndromes. Circulation 2004; 109: 1230–5
   PubMed Web of Science ®Google Scholar
• Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749–95
   PubMed Web of Science ®Google Scholar
• Jonasson L, Holm J, Hansson GK. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A 1988; 85: 2303–6
   PubMed Web of Science ®Google Scholar
• Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001; 104: 852–5
   PubMed Web of Science ®Google Scholar
• Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005; 293: 165–71
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, et al. C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20–8
   PubMed Web of Science ®Google Scholar
• Nissen SE, Murat Tuzcu E, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352: 29–38
   PubMed Web of Science ®Google Scholar
• Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001; 21: 1712–9
   PubMed Web of Science ®Google Scholar
• Ehrenstein MR, Jury EC, Mauri C. Statins for atherosclerosis—as good as it gets?. N Engl J Med 2005; 352: 73–5
   PubMed Web of Science ®Google Scholar
• Zhou X, Caligiuri G, Hamsten A, Lefvert AD, Hansson GK. LDL immunisation induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 108–14
   PubMed Web of Science ®Google Scholar
• Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, Libby P, et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002; 106: 1708–15
   PubMed Web of Science ®Google Scholar
• Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation 1994; 89: 2421–32
   PubMedGoogle Scholar
• Myles JL, Ratliff NB, McMahon JT, Golding LR, Hobbs RE, Rincon G, et al. Reversibility of myocyte injury in moderate and severe acute rejection in cyclosporine-treated cardiac transplant patients. Arch Pathol Lab Med 1987; 111: 947–52
   Google Scholar
• Schuurhuis DH, Laban S, Toes RE, Ricciardi-Castagnoli P. Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J Exp Med 2000; 192: 145–50
   PubMed Web of Science ®Google Scholar
• Wang JC, Livingstone AM. Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo. J Immunol 2003; 171: 6339–43
   PubMed Web of Science ®Google Scholar
• Kam CM, Hudig D, Powers JC. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 2000; 1477: 307–23
   PubMedGoogle Scholar
• Henkart PA. Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol 1985; 5: 31–58
   Google Scholar
• Moulian N, Berrih-Aknin S. Fas/APO-1/CD95 in health and autoimmune disease: thymic and peripheral aspects. Semin Immunol 1998; 10: 449–56
   PubMed Web of Science ®Google Scholar